Journals / Food and Health / 2020 / Cilt: 6 - Sayı: 4

A co-culture study to determine the supportive role of probiotics on immune system against cancer cells

Pages
287–298
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In conclusion, the use of LA-5 could be encouraged as a dietary supplementary for cancer patients due to its superior effects on immune stimulation.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this study, two different in vitro co-culture systems were established in order to determine the supportive role of probiotic Lactobacillus acidophilus LA-5 on macrophages when used in combination with doxorubicin in both human- and mouse-origin cancerous cell lines.
📊
Key Findings & Data:First, a co-culture study was undertaken using RAW 264.7 mouse macrophage cells that activated by LA-5 against 4T1 mouse triple negative breast adenocarcinoma cells.
💡
Conclusion & Impact:In conclusion, the use of LA-5 could be encouraged as a dietary supplementary for cancer patients due to its superior effects on immune stimulation.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

In this study, two different in vitro co-culture systems were established in order to determine the supportive role of probiotic Lactobacillus acidophilus LA-5 on macrophages when used in combination with doxorubicin in both human- and mouse-origin cancerous cell lines. First, a co-culture study was undertaken using RAW 264.7 mouse macrophage cells that activated by LA-5 against 4T1 mouse triple negative breast adenocarcinoma cells. After the initial study, a second co-culture was performed using THP-1 human monocyte-like cells activated by LA-5 against CaCo-2 human colorectal adenocarcinoma cells. The supplementary potential of LA-5 on the macrophages was evaluated by investigating the viabilities of 4T1 and CaCo-2 cells via an MTT test. The data obtained in the study indicated that the viability of cancerous cells 4T1 and CaCo-2 decreased to ≈40% and ≈30% in the groups that used LPS-activated macrophages stimulated with LA-5 and the combination of LA-5 and doxorubicin (1/2 IC50), respectively. In conclusion, the use of LA-5 could be encouraged as a dietary supplementary for cancer patients due to its superior effects on immune stimulation.

🔖

Cite This Article

NALBANSOY, A., ÖZVEREL, C. S., KIŞLA, D. (2020). A co-culture study to determine the supportive role of probiotics on immune system against cancer cells. Food and Health, Cilt: 6 - Sayı: 4, 287–298. https://ajindex.com/articles/158766

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Baldwin, C., Millette, M., Oth, D., Ruiz, M.T., Luquet, F.- M., Lacroix, M. (2010). Probiotic Lactobacillus acidophilus and L. casei mix sensitize colorectal tumoral cells to 5- fluorouracil-induced apoptosis. Nutrition and Cancer, 62, 371-78. http://doi.org/10.1080/01635580903407197
  2. Brown, A.C., Valiere, A. (2004). Probiotics and medical nutrition therapy. Nutrition in Clinical Care, 7(2), 56-68.
  3. Chen, C., Chan, H.M., Kubow, S. (2007). Kefir extracts suppress in vitro proliferation of estrogen-dependent human breast cancer cells but not normal mammary epithelial cells. Journal of Medicinal Food, 10(3), 416-422. http://doi.org/10.1089/jmf.2006.236
  4. Couzin-Frankel, J. (2013). Cancer immunotherapy. Science, 342(6165), 1432-1433. http://doi.org/10.1126/science.342.6165.1432
  5. Damaskos, D., Kolios, G. (2008). Probiotics and prebiotics in inflammatory bowel disease: microflora ‘on the scope’. British Journal of Clinical Pharmacology, 65(4), 453-467. http://doi.org/10.1111/j.1365-2125.2008.03096.x
  6. Dasari, S., Kathera, C., Janardhan, A., Kumar, A.P., Viswanath, B. (2017). Surfacing role of probiotics in cancer prophylaxis and therapy: A systematic review. Clinical Nutrition, 36(6), 1465-1472. http://doi.org/10.1016/j.clnu.2016.11.017
  7. Duary, R.J., Batish, V.K., Grover, S. (2014). Immunomodulatory activity of two potential probiotic strains in LPS-stimulated HT-29 cells. Genes & Nutrition, 9(3), 398. http://doi.org/10.1007/s12263-014-0398-2
  8. Fujihara, M., Muroi, M., Tanamoto, K., Suzuki, T., Azuma, H., Ikeda, H. (2003). Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex. Pharmacology & Therapeutics, 100(2), 171-194. https://doi.org/10.1016/j.pharmthera.2003.08.003
  9. Faghfoori, Z., Gargari, B.P., Gharamaleki, A.S., Bagherpour, H., Khosroushahi, A.Y. (2015). Cellular and molecular mechanisms of probiotics effects on colorectal cancer. Journal of Functional Foods, 18(A), 463-472. https://doi.org/10.1016/j.jff.2015.08.013
  10. Foo, N.-P., Yang, H.O., Chiu, H.-H., Chan, H.-Y., Liao, C.-C., Yu, C.-K., Wang, Y.-J. (2011). Probiotics prevent the development of 1,2-dimethylhydrazine (DMH)-induced colonic tumorigenesis through suppressed colonic mucosa cellular proliferation and increased stimulation of macrophages. Journal of Agricultural and Food Chemistry, 59(24), 13337- 13345. https://doi.org/10.1021/jf203444d
  11. Galdeano, C.M., de Moreno de LeBlanc, A., Vinderola, G., Bibas Bonet, M.E., Perdigon, G. (2007). Proposed mod